In Brief: New Benzodiazepine Warnings
Date: November 2, 2020
Issue #:
1610Summary:
The FDA now requires boxed warnings in the package
inserts of benzodiazepines describing the potential for
these drugs to be abused and misused and to cause
addiction and physical dependence. Benzodiazepine
labels have contained a boxed warning about a risk of
serious drug interactions with opioids since 2016.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Source Type: research